קמזיוס 2.5 מ"ג - Camzyos 2.5 mg

× ×ª×× × ×ª×¨××¤×

×××¨×©×

××× ×× ×× × ××¡×¤××	×§×××××¡ 10 ×"× - Camzyos 10 mg ×§×××××¡ 15 ×"× - Camzyos 15 mg ×§×××××¡ 5 ×"× - Camzyos 5 mg
×§×××¦× ×¤×¨××§××××××ª (ATC4)	C01EB Other cardiac preparations
××¨××× ×¤×¢×× (ATC5)	Â Mavacamten 2.5 MG âC01EB24
×¦××¨×ª ××ª×	×¤××× - PER OS
×¦××¨×ª ××× ××	×§×¤×¡××××ª, CAPSULES ××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××
××ª××××	CAMZYOS is indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms
×¢××× ××¨××¤× ×××××¨××ª ××¢×××	Â ×¢××× ××¨××¤× 31.01.2024 Â

×¢××× ××¦×¨××

Â

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×§×××××¡ 2.5 ×"× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	BRISTOL-MYERS SQUIBB COMPANY, USA
×©× ××¢× ××¨××©××	BRISTOL, MYERS SQUIBB (ISRAEL) LIMITED, ISRAEL
×¨××©×××	×ª××¨×× ×××©×: 5/2022. ×¨××©××× ××ª××¨××:
×ª××¨×× ×¢×××× ×××¨××	16/07/2024

השינוי האחרון נעשה בֹ־16 ביולי 2024 ב־03:10